Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Villejuif 21 Marseille 17 Paris 17 Lyon 15 Toulouse 11
Narrow the registerReset
Recruitment status
Phase
Site location
Villejuif21 Marseille17 Paris17 Lyon15 Toulouse11
All 52 locations
Target enrolment
to

Trials with a site in Paris

17 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
GlaxoSmithKline
Phase 1/2
346
Dijon, Marseille, Paris, Poitiers, Rennes, Villejuif
2025-06-11
Recruiting
GlaxoSmithKline
Phase 2
80
Le Mans, Nice, Paris, Poitiers, Toulouse
2025-06-05
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
GlaxoSmithKline
Phase 1/2
83
Bordeaux, Lyon, Paris, Strasbourg, Villejuif
2025-03-06
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
GlaxoSmithKline
Phase 2
68
Angers, Brest, Lyon, Nice, Nîmes, Paris, Poitiers
2025-02-28
Active, closed
GlaxoSmithKline
Phase 2
153
Marseille, Melun, Montpellier, Nantes, Paris
2024-09-17
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Bobigny, Brest, Paris, Toulouse
2023-09-13
Recruiting
GlaxoSmithKline
Phase 3
892
Lyon, Marseille, Nantes, Paris, Pessac, Rennes, Rouen, Saint-Priest-en-Jarez
2023-08-01
Active, closed
GlaxoSmithKline
Phase 2
154
Besançon, Marseille, Paris, Pessac, Rennes
2023-04-03
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
GlaxoSmithKline
Phase 2
284
Angers, Limoges, Paris, Pierre-Bénite, Strasbourg
2023-01-02
Active, closed
GlaxoSmithKline
Phase 3
163
La Roche-sur-Yon, Nantes, Paris
2022-07-14
Active, closed
GlaxoSmithKline
Phase 2
360
Clichy, Lyon, Paris, Pessac, Rennes, Strasbourg
2021-12-14
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Active, closed
GlaxoSmithKline
Phase 2
237
Le Mans, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2018-05-03
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-france/city/paris

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Paris that also match the filters currently applied.

How many clinical trials are recruiting in Paris?

8 of the 17 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Paris), 17 studies
PhaseStudiesRecruitingShare
Phase 29352.9%
Phase 1/23217.6%
Phase 33217.6%
Phase 1105.9%
Phase 2/3115.9%

Most active sponsors

Lead sponsors with the most studies (Paris)
Lead sponsorStudiesRecruiting
GlaxoSmithKline178
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.